Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) EPS (Basic) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed EPS (Basic) for 16 consecutive years, with $0.68 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 38.78% to $0.68 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.55, a 30.1% increase, with the full-year FY2025 number at $2.55, up 30.1% from a year prior.
  • EPS (Basic) was $0.68 for Q4 2025 at Lemaitre Vascular, down from $0.77 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.77 in Q3 2025 to a low of $0.16 in Q2 2022.
  • A 5-year average of $0.4 and a median of $0.38 in 2023 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): soared 135.29% in 2021, then tumbled 60.0% in 2022.
  • Lemaitre Vascular's EPS (Basic) stood at $0.28 in 2021, then decreased by 7.14% to $0.26 in 2022, then soared by 50.0% to $0.39 in 2023, then increased by 25.64% to $0.49 in 2024, then soared by 38.78% to $0.68 in 2025.
  • Per Business Quant, the three most recent readings for LMAT's EPS (Basic) are $0.68 (Q4 2025), $0.77 (Q3 2025), and $0.61 (Q2 2025).